There’s never a dull moment in Australia for private equity behemoth Brookfield. As the firm attempts to navigate Healthscope ...

Dubai Saudi Arabia has rapidly become a pivotal player in the Gulf Cooperation Council's private equity sector, driven by ...

Once the hottest property in biotech, gene therapy company bluebird bio has been sold for less than $500 million after a long series of setbacks.

Private equity fundraising struggled in 2024, with total capital raised declining for the third consecutive year. Read more ...